More advanced manufactured materials are being produced in the 21st century, including, for example, engineered nanoparticles whose exact impact on the environment and human health are unknown, but whose effects could be quite negative. To better understand such threats, researchers are using the Notre Dame Linked Experimental Ecosystem Facility (ND-LEEF) to study how these engineered nanoparticles will move and spread in the natural environment.
Notre Dame’s nanotechnology research efforts date back to the 1980s. In the three decades since, research at the University’s Center for Nano Science and Technology (NDnano) has grown and evolved in a forward-thinking and distinctive way.
Notre Dame researchers have recently published a study on a new diagnostic method that uses gold nanoparticles, requires little to no expertise, and provides results in minutes.
During the Alumni Association’s annual reunion event, Notre Dame Research will host an open house from 9:00 a.m. to 12:00 p.m. on the first Friday of June.
The National Science Foundation (NSF) has recognized 10 University of Notre Dame faculty members for their excellence in research with Early Career Development (CAREER) Awards.
The event will feature presentations from faculty across the region, including Purdue University and the University of Michigan, and focus on highlighting new trends of in-situ and high-resolution electron microscopy for nanotechnology, materials, and biosciences.
Researchers at the University of Notre Dame are active in many areas of modern electronics research, including materials, devices, architectures, and systems.
Small ubiquitin-like modifier (SUMO) proteins are small peptides that get added on to other proteins to regulate their activity. While SUMO has many regulatory roles in cells, it is especially important for controlling gene expression during early development. Just a few years ago this connection between SUMO and gene regulation was relatively unknown, but now, Notre Dame researchers are exploring how a disruption to the SUMO protein’s ability to regulate embryo development may be linked to congenital heart defects.
The Office of Technology Transfer (OTT) is now accepting nominations for the 1st Source Bank Technology Commercialization competition. The winner will be revealed at the seventh annual commercialization event on April 18, 2017, and will receive a $20,000 cash award.
Diabetes is a metabolic disease in which the body has an inability to produce enough insulin. In the United States alone, it is estimated that the illness affects nearly 30 million diagnosed and undiagnosed people, and treatment often includes patients using an intravenous or IV method to get insulin into their system. This uncomfortable and inconvenient form of treatment can require anywhere from two to four injections a day, but a Notre Dame researcher is working to combat this problem with a less frequent, oral delivery system.
In the United States alone, there are nearly 240,000 breast cancer diagnoses each year, and one in eight women will develop breast cancer at some point in her lifetime. To date, mammograms are the best diagnostic technology for breast cancer. A mammogram’s ability to detect tumors at early stages has made breast cancer one of the most treatable forms of cancer, but there are still almost 50,000 missed diagnoses every year.
The Indiana Clinical and Translational Sciences Institute (Indiana CTSI) recently announced multiple recipients of the Collaboration in Translational Research Pilot (CTR) Grant Program. The CTR Program seeks to foster and encourage collaboration across Indiana CTSI partner institutions by awarding up to $75,000 for the projects.
The University of Notre Dame has received $128 million in research funding for fiscal year 2016 — the second highest in its history. In fiscal year 2015, the University’s research funding was its highest of all time, reaching $133 million.
Consider that a human hair is anywhere from 60,000 to 80,000 nanometers in size. A plasmonic nanoparticle, which is a nanoparticle made of noble metals like gold and silver, at their largest are just 100 nanometers, but pack a big punch.
The University of Notre Dame will attend the 2016 BIO International Convention, which is hosted by the Biotechnology Innovation Organization (BIO) from June 6 - 9, 2016 in San Francisco. Represented Notre Dame Research groups at the event include the Harper Cancer Research Institute (HCRI), the Center for Nano Science and Technology (NDnano), as well as Technology Transfer.
Notre Dame Research will be participating in the Alumni Association’s Annual Reunion event on the first Friday of June on the third floor of the Main Building. From 9 a.m. to 12 p.m., the dome will be open to tours, where several offices will open their doors to alumni, faculty, staff, and friends of the University. Additionally, other buildings on campus will also be open for tours throughout the day.
On May 17 – 18, 2016 the Notre Dame Integrated Imaging Facility (NDIIF) is hosting their third annual Midwest Imaging and Microanalysis Workshop at the University of Notre Dame. The two-day event was jointly organized by the Department of Electrical Engineering, along with support from Notre Dame Research and other Colleges, departments, and centers. Researchers who utilize imaging technologies are invited to learn about the new trends in high resolution and in-situ electron microscopy for nanotechnology, materials, and bio-sciences.
Notre Dame Research has provided more than 35 researchers with awards from the Internal Grants Program for 2016. The grant awardees spanned the University in four program categories: Faculty Research Support (Initiation), Faculty Research Support (Regular), Equipment Restoration and Renewal, and Library Acquisitions.
PittCon Conference and Expo is the world’s largest annual premier conference on laboratory science.